PMC:7299399 / 19097-19285 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T88","span":{"begin":113,"end":118},"obj":"Body_part"}],"attributes":[{"id":"A88","pred":"fma_id","subj":"T88","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"st certain tumor antigens.64 The design of such nanocarriers, which will need to escape recognition by scavenger cells and to be nontoxic and nonimmunogenic, is a challenge that will requi"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T71","span":{"begin":11,"end":16},"obj":"Disease"}],"attributes":[{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"st certain tumor antigens.64 The design of such nanocarriers, which will need to escape recognition by scavenger cells and to be nontoxic and nonimmunogenic, is a challenge that will requi"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T190","span":{"begin":113,"end":118},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T191","span":{"begin":161,"end":162},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"st certain tumor antigens.64 The design of such nanocarriers, which will need to escape recognition by scavenger cells and to be nontoxic and nonimmunogenic, is a challenge that will requi"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T127","span":{"begin":17,"end":25},"obj":"Chemical"}],"attributes":[{"id":"A127","pred":"chebi_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"}],"text":"st certain tumor antigens.64 The design of such nanocarriers, which will need to escape recognition by scavenger cells and to be nontoxic and nonimmunogenic, is a challenge that will requi"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":11,"end":16},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"st certain tumor antigens.64 The design of such nanocarriers, which will need to escape recognition by scavenger cells and to be nontoxic and nonimmunogenic, is a challenge that will requi"}

{"project":"LitCovid-PubTator","denotations":[{"id":"275","span":{"begin":11,"end":16},"obj":"Disease"}],"attributes":[{"id":"A275","pred":"tao:has_database_id","subj":"275","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"st certain tumor antigens.64 The design of such nanocarriers, which will need to escape recognition by scavenger cells and to be nontoxic and nonimmunogenic, is a challenge that will requi"}

{"project":"2_test","denotations":[{"id":"32519842-27281205-158490","span":{"begin":26,"end":28},"obj":"27281205"}],"text":"st certain tumor antigens.64 The design of such nanocarriers, which will need to escape recognition by scavenger cells and to be nontoxic and nonimmunogenic, is a challenge that will requi"}